[go: up one dir, main page]

AU1293400A - Enzymatic treatment and prevention of hypertrophic skin - Google Patents

Enzymatic treatment and prevention of hypertrophic skin

Info

Publication number
AU1293400A
AU1293400A AU12934/00A AU1293400A AU1293400A AU 1293400 A AU1293400 A AU 1293400A AU 12934/00 A AU12934/00 A AU 12934/00A AU 1293400 A AU1293400 A AU 1293400A AU 1293400 A AU1293400 A AU 1293400A
Authority
AU
Australia
Prior art keywords
prevention
enzymatic treatment
hypertrophic skin
hypertrophic
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12934/00A
Inventor
Tatyana Elbakyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO-SILK Ltd
Original Assignee
BIO SILK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO SILK Ltd filed Critical BIO SILK Ltd
Publication of AU1293400A publication Critical patent/AU1293400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12934/00A 1998-11-23 1999-11-22 Enzymatic treatment and prevention of hypertrophic skin Abandoned AU1293400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL127209 1998-11-23
IL12720998A IL127209A0 (en) 1998-11-23 1998-11-23 Composition and method for treatment of hypertrophic skin accumulations and their prevention
PCT/IL1999/000629 WO2000030578A1 (en) 1998-11-23 1999-11-22 Enzymatic treatment and prevention of hypertrophic skin

Publications (1)

Publication Number Publication Date
AU1293400A true AU1293400A (en) 2000-06-13

Family

ID=11072176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12934/00A Abandoned AU1293400A (en) 1998-11-23 1999-11-22 Enzymatic treatment and prevention of hypertrophic skin

Country Status (6)

Country Link
EP (1) EP1152723A1 (en)
JP (1) JP2003517448A (en)
AU (1) AU1293400A (en)
GB (1) GB2343844B (en)
IL (1) IL127209A0 (en)
WO (1) WO2000030578A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187169A1 (en) * 2001-05-11 2002-12-12 Shoujun Chen Kavalactone compositions
DE10221194B4 (en) * 2002-05-13 2005-02-10 Fryda, Waltraud, Dr.med. Hyaluronidase containing skin care product
MXPA03011987A (en) 2003-12-19 2005-06-23 Osio Sancho Alberto Method for treating presbyopia by inducing changes in the corneal power and physiology.
FR2880262B1 (en) * 2005-01-03 2013-11-08 Oreal COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
ES2994608T3 (en) 2012-08-10 2025-01-27 Osio Corp D/B/A Yolia Health Contact lens use in the treatment of an ophthalmologic condition
EP4134149A1 (en) * 2021-08-11 2023-02-15 Lenzing Aktiengesellschaft Face mask with a carrier layer
EP4387653B1 (en) * 2021-08-25 2026-02-11 Fibrosoft (AU) Pty Ltd A pharmaceutical composition comprising plasminogen activator and hyaluronidase for use in treating fibromatosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB792544A (en) * 1956-05-07 1958-03-26 American Home Prod Therapeutic composition
US4154823A (en) * 1976-06-10 1979-05-15 Schutt Steven R Skin treatment compositions and methods of using same
AU568626B2 (en) * 1983-01-05 1988-01-07 Institut Pasteur Preparation having a high collagenolytic activity and pharmaceutical compositions containing it
FR2558171B1 (en) * 1984-01-12 1986-08-01 Oreal POLYMERIC MATERIAL HAVING ENZYMATIC ACTION, METHOD FOR PREPARING THE SAME, AND USE THEREOF AS A MEDICAMENT
EP0162007A1 (en) * 1984-04-18 1985-11-21 Geriaco AG Stable and durable insulin preparation for Acne vulgaris treatment
US4784653A (en) * 1987-06-22 1988-11-15 Johnson & Johnson Patient Care, Inc. Absorbent adhesive dressing
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
IL104734A0 (en) * 1993-02-15 1993-06-10 Univ Bar Ilan Bioactive conjugates of cellulose with amino compounds
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
DE19503338C2 (en) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Pharmaceutical form for delivering collagenase to wounds and process for their production and their use
IT1276684B1 (en) * 1995-06-08 1997-11-03 Bioextech Inc WATER-SOLUBLE FORMULATIONS OF STABILIZED COLLAGENASE AND PROCEDURE FOR THEIR PREPARATION
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
DE19627232A1 (en) * 1996-07-05 1998-01-08 Basf Ag Defined enzyme mixtures for cosmetic purposes

Also Published As

Publication number Publication date
GB2343844B (en) 2000-10-25
IL127209A0 (en) 1999-09-22
EP1152723A1 (en) 2001-11-14
GB2343844A8 (en) 2000-06-14
WO2000030578A1 (en) 2000-06-02
GB2343844A (en) 2000-05-24
JP2003517448A (en) 2003-05-27
GB9902711D0 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
AU2197100A (en) Treatment of tooth surfaces and substance therefor
AU4717301A (en) Catheter assembly and method of use
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU3082699A (en) Method of treating skin irritation
AU3118499A (en) Soft tissue reconstructor and method of use
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU1556497A (en) Agents for the treatment and prevention of aids
AU2845400A (en) Treatment and prevention of immune rejection reactions
AU3896900A (en) Treatment of pain
AU7601400A (en) Treatment and prevention of hepatic disorders
AU1293400A (en) Enzymatic treatment and prevention of hypertrophic skin
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU2964199A (en) Prevention and treatment of adhesions
AU2255201A (en) Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU2420101A (en) Method and composition for the treatment of pain
AU1712395A (en) Medical application of bromelain
AU2750297A (en) Methods for prevention and/or treatment of neutropenia
AU2612295A (en) Enzymatic treatment of soy
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU3735900A (en) Methods of treatment and prevention of restenosis
AU3762397A (en) Treatment and prevention of helicobacter infection
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU4556899A (en) Prevention and treatment of sepsis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 14, NO 35, PAGE(S) 6267-6268 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 12934/00

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase